The number of aging Americans 65 years and older is projected to nearly double over the next 40 years, reaching 80 million in 2040. As the U.S. population ages, so too does the prevalence of medically complex patients with conditions that require ongoing medical attention, limit activities of daily living or both.
Because lifestyle behaviors are both a choice the employee makes, as well as a clear determinant of total health insurance rates, it follows that the employee’s share of contribution should adjust either upwards or downwards based on their lifestyle behaviors.
Emphasizing data efficiencies and quality will benefit payers and providers — and patients.
As we continue to navigate the unknowns of the current pandemic, it appears we're still a long way off from living in a true post-COVID-19 era. Until then, improved health outcomes can still be realized through effective population health strategies, providing adequate financial resources that are available and encompassing all the determinants of health in communities, including social, behavioral and environmental factors.
CivicaScript, a generic medication manufacturer, is modeling itself as public utility. It launched its first product, abiraterone 250 mg tablets, late last year and is gearing up to make its own low-cost insulin.
Federally Qualified Health Centers have been the safety net for individuals in need for decades. However, even with increasing demand for their services – tripling the number of patients served to more than 28 million since 2000 – FQHCs are not immune from challenges stemming from the pandemic.
Assembly Bio’s established areas of research is focused on herpesviruses (HSV), hepatitis B virus and hepatitis D virus.
A new study points to disparities for patients in respiratory failure, which can have dire consequences. The lead researchers talk about the implications.
The United States does not have a uniform health system and has no universal healthcare coverage. The health disadvantage of the U.S. relative to other high-income countries is health disparities in health services.
Efforts to improve education on biosimilars are a start, but payer policies must catch up to ensure real change.
The COVID-19 pandemic has led payers and providers to embrace electronic encrypted documents and other technology — and that has fostered greater collaboration between them.
The idea of software creating and delivering content to patients and plan members would have been unthinkable in the recent past. Now it is becoming essential to a good customer experience for patients.
Member experience, outcomes and medication adherence are the key areas of performance that Medicare Advantage plans should focus on to improve Star Ratings.
Over the past 20 years, the age-adjusted mortality rate for obesity-related cardiovascular mortality increased by 415% for American Indian or Alaska Native individuals.
The process of building digital peer support experiences requires taking in feedback from users and their caregivers to address risk concerns, add new features and continuously improve the user experience.
The rapidly evolving landscape of extended reality technologies has presented us with unique tools to enhance our virtual interactions and come closer to the therapeutic experience that is so important to successful delivery of effective and high-quality remote care.
The efficiency and ease of tools that support virtualization will set the stage for the future of cancer care.
Three differentiators that separate leaders from chasers in virtual health transformation.
Labs are justifying larger respiratory panels as simplifying a physician’s job in diagnosing via lab testing, but payers need to observe the multiplex testing trend.
Spending the extra time and effort to address a patient’s body, mind, and spirit is a good business practice for physicians. We need to achieve this in our own practices and at a systemic level – but how?
CMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.
Momentum is building for biosimialrs but robust coverage for lower-cost agents, including biosimilars, is needed.
The benefits of addressing barriers and increasing access to HIV PrEP therapies to high-risk populations across the globe.
Cognitive behavioral therapy with exposure treatment might help but few people with AD receive any form of behavioral intervention, say Dorian Kern and colleagues from Karolinska Institutet, Stockholm.